Clinical Development of the E75 Vaccine in Breast Cancer

Breast Care - Switzerland
doi 10.1159/000446097
Full Text
Abstract

Available in full text

Categories
SurgeryOncology
Date
Authors
Publisher

S. Karger AG

Related search

Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

Clinical Cancer Research
Cancer ResearchOncology
2008English

Development of a Vaccine Targeting Triple-Negative Breast Cancer

2013English

Dissecting the Mechanism of T Cell Tolerance for More Effective Breast Cancer Vaccine Development

2004English

Progress in the Development of a Cervical Cancer Vaccine

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2006English

Host Microenvironment in Breast Cancer Development: Epithelial–mesenchymal Transition in Breast Cancer Development

Breast Cancer Research
Cancer ResearchOncology
2003English

Recombinant Vaccine Strategies for Breast Cancer Prevention

1999English

The Role of AhR in Breast Cancer Development

2004English

Management of Breast Cancer by Vaccine: Fact or Fiction

Journal of the Islamic Medical Association of North America
2013English

[OPINION] Problems of Cancer Vaccine Therapy Development

Drug Delivery System
Pharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy